Survival of tumor cells after proton irradiation with ultra-high dose rates
By: Susanne Auer, Volker Hable, Christoph Greubel, Guido A Drexler, Thomas E Schmid, Claus Belka, Gunther Dollinger and Anna A Friedl

Radiation Oncology 2011, 6:139 doi:10.1186/1748-717X-6-139
Published: 18 October 2011

Abstract (provisional)

Background and Purpose

Laser acceleration of protons and heavy ions may in the future be used in radiation therapy. Laser-driven particle beams are pulsed and ultra high dose rates of >109 Gy s-1 may be achieved. Here we compare the radiobiological effects of pulsed and continuous proton beams.

Materials and Methods

The ion microbeam SNAKE at the Munich tandem accelerator was used to directly compare a pulsed and a continuous 20 MeV proton beam, which delivered a dose of 3 Gy to a HeLa cell monolayer within < 1 ns or 100 ms, respectively. Investigated endpoints were G2 phase cell cycle arrest, apoptosis, and colony formation.

Results

At 10 h after pulsed irradiation, the fraction of G2 cells was significantly lower than after irradiation with the continuous beam, while all other endpoints including colony formation were not significantly different. We determined the relative biological effectiveness (RBE) for pulsed and continuous proton beams relative to x-irradiation as 0.91 +/- 0.26 and 0.86 +/- 0.33 (mean and SD), respectively.

Conclusions

At the dose rates investigated here, which are expected to correspond to those in radiation therapy using laser-driven particles, the RBE of the pulsed and the (conventional) continuous irradiation mode do not differ significantly.

The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.







Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements